Healthcare -
Biotechnology - NASDAQ - US
$ 0.96
-5.88 %
$ 200 M
Market Cap
-1.35
P/E
SGMO - REVENUE
Revenue SGMO - Sangamo Therapeutics, Inc.
176 M
LAST VALUE
26.17%
2 YEAR CAGR
15.85%
5 YEAR CAGR
22.00%
10 YEAR CAGR